Provided By GlobeNewswire
Last update: Apr 23, 2025
IRVINE, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a global provider of advanced diagnostic solutions, announced today that its Fortel® Ulcer Test has been approved for sale by the United Arab Emirates (UAE) Ministry of Health and Prevention. This regulatory approval enables Biomerica to introduce its rapid point-of-care test for Helicobacter pylori (H. pylori) infection across the UAE—a region where gastrointestinal diseases are a growing public health concern.
Read more at globenewswire.comNASDAQ:BMRA (8/8/2025, 8:21:20 PM)
3.11
0 (0%)
Find more stocks in the Stock Screener